Clinical Trial Details
| Trial ID: | L2879 |
| Source ID: | NCT00363844 |
| Associated Drug: | Sitagliptin Phosphate |
| Title: | Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: Sitagliptin phosphate |
| Outcome Measures: | Primary: safety, 52 weeks|tolerability, 52 weeks | Secondary: HbA1c, 52 weeks|Plasma glucose, 52 weeks |
| Sponsor/Collaborators: | Sponsor: Ono Pharmaceutical Co. Ltd |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 209 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2006-08 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2012-06-14 |
| Locations: | Chubu Region, Chubu, Japan|Chugoku Region, Chugoku, Japan|Hokkaido Region, Hokkaido, Japan|Kanto Region, Kanto, Japan|Kinki Region, Kinki, Japan|Kyushu Region, Kyushu, Japan|Shikoku Region, Shikoku, Japan|Tohoku Region, Tohoku, Japan |
| URL: | https://clinicaltrials.gov/show/NCT00363844 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|